Adina Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 0.95 M
- Revenue Growth -55.06%
- Profit Growth -199.39%
- Ebitda -6.25%
- Net Worth -9.03%
- Total Assets 10.66%
About Adina Biotech
Adina Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 March 2012 and has a history of 12 years and 11 months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹0.95 M.
Raveendra Singh, Ashok Singh, and Sunil Singh serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51101UP2012PTC049188
- Company No.
049188
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2012
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Adina Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raveendra Singh  | Director | 03-Mar-2012 | Current |
| Ashok Singh | Director | 18-Oct-2018 | Current |
| Sunil Singh | Director | 10-Jul-2016 | Current |
Financial Performance of Adina Biotech.
Adina Biotech Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 55.06% decrease. The company also saw a substantial fall in profitability, with a 199.39% decrease in profit. The company's net worth dipped by a decrease of 9.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adina Biotech?
In 2018, Adina Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fames Global LlpAshok Singh is a mutual person
- Siddhartha Colonisers & Construction Private Limited
Ashok Singh is a mutual person
- Devragh Project And Process Engineering Private Limited
Sunil Singh is a mutual person
Charges (Loans)
₹0.95 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Aug 2016 | Indian Bank | ₹0.95 M | Open |
How Many Employees Work at Adina Biotech?
Unlock and access historical data on people associated with Adina Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adina Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adina Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
